Polyamines_NNS
in_IN
human_JJ
breast_NN
cancer_NN
and_CC
its_PRP$
relations_NNS
to_TO
classical_JJ
prognostic_JJ
features_NNS
:_:
clinical_JJ
implications_NNS
._.

Experimental_JJ
evidence_NN
suggest_VBP
an_DT
important_JJ
role_NN
of_IN
polyamines_NNS
in_IN
breast_NN
cancer_NN
development_NN
._.

Polyamines_NNS
have_VBP
been_VBN
determined_VBN
in_IN
tissue_NN
and_CC
erythrocyte_NN
samples_NNS
from_IN
100_CD
patients_NNS
with_IN
primary_JJ
invasive_JJ
breast_NN
cancer_NN
and_CC
30_CD
patients_NNS
with_IN
fibroadenomas_NNS
._.

Statistical_JJ
analysis_NN
was_VBD
performed_VBN
in_IN
order_NN
to_TO
determine_VB
the_DT
prognostic_JJ
value_NN
of_IN
the_DT
polyamine_NN
patterns_NNS
of_IN
tumor_NN
tissues_NNS
and_CC
erythrocytes_NNS
in_IN
comparison_NN
with_IN
clinical_JJ
and_CC
histological_JJ
prognostic_JJ
factors_NNS
._.

In_IN
malignant_JJ
tissues_NNS
,_,
polyamine_NN
levels_NNS
were_VBD
significantly_RB
higher_JJR
than_IN
in_IN
benign_JJ
tissues_NNS
._.

They_PRP
correlated_VBD
with_IN
markers_NNS
of_IN
tumor_NN
aggressivity_NN
-LRB-_-LRB-
axillary_JJ
node_NN
involvement_NN
and_CC
especially_RB
with_IN
markers_NNS
of_IN
high_JJ
mitotic_JJ
rate_NN
as_IN
Ki-67_NN
staining_NN
,_,
histological_JJ
grade_NN
-RRB-_-RRB-
._.

No_DT
correlation_NN
was_VBD
found_VBN
between_IN
estrogen_NN
and_CC
progesterone_NN
status_NN
,_,
tumor_NN
size_NN
and_CC
polyamine_NN
concentrations_NNS
._.

Erythrocyte_NN
polyamines_NN
levels_NNS
were_VBD
identical_JJ
between_IN
cancer_NN
patients_NNS
and_CC
controls_NNS
._.

The_DT
knowledge_NN
of_IN
the_DT
polyamine_NN
pattern_NN
in_IN
breast_NN
cancer_NN
could_MD
become_VB
useful_JJ
in_IN
clinical_JJ
practice_NN
particularly_RB
if_IN
polyamine_NN
metabolism_NN
is_VBZ
targeted_VBN
as_IN
a_DT
therapeutic_JJ
approach_NN
._.

